James T. LaFrance's Insider Trades & SAST Disclosures
James T. LaFrance's most recent trade in Aspira Women`s Health Inc was a trade of 110,305 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James T. LaFrance.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aspira Women`s Health Inc | James T. LaFrance | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 110,305 | 110,305 | - | - | Employee Stock Option (Right to Buy) | |
| Aspira Women`s Health Inc | James T. LaFrance | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 72,937 | 496,129 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | James T. LaFrance | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 502 | 502 | - | - | Employee Stock Option (Right To Buy) | |
| Aspira Women`s Health Inc | James T. LaFrance | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 330 | 423,192 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | James T. LaFrance | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 720 | 720 | - | - | Employee Stock Option (Right To Buy) | |
| Aspira Women`s Health Inc | James T. LaFrance | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 423 | 422,862 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | James T. LaFrance | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 15,412 | 15,412 | - | - | Employee Stock Option (Right to Buy) | |
| Aspira Women`s Health Inc | James T. LaFrance | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 9,205 | 422,439 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | James T. LaFrance | Director | 02 Jun 2020 | 5,021 | 434,480 (0%) | 0% | 1.8 | 9,038 | Common Stock | |
| Aspira Women`s Health Inc | James T. LaFrance | Director | 02 Jun 2020 | 5,021 | 0 | - | - | Warrants to acquire Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges